Clinical Trial Update: Lactulose Supplementation in Premature Infants [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluating lactulose supplementation in premature infants has completed. The study targeted necrotizing enterocolitis and sepsis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Necrotizing Enterocolitis
• Sepsis

Drugs mentioned

• LACTULOSE (Lactulose)

Snippet

Sponsor: Bnai Zion Medical Center | Conditions: Necrotizing Enterocolitis, Sepsis | Phase 2 | Status: COMPLETED